Risperidone: Difference between revisions
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
[[File:Risperidone orodispersible 2mg.mp3]] | [[File:Risperidone orodispersible 2mg.mp3]] | ||
==Common Strengths of | ==Common Strengths of Risperidone Tablet== | ||
Brexpiprazole tablets are available in the following strengths: | Brexpiprazole tablets are available in the following strengths: | ||
*0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tablets; 1 mg/mL oral solution | *0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tablets; 1 mg/mL oral solution | ||
| Line 30: | Line 30: | ||
==Drug Usage== | ==Drug Usage== | ||
Risperidone is used for: | |||
* Treatment of schizophrenia | * Treatment of schizophrenia | ||
* | * Acute treatment of manic or mixed episodes associated with bipolar disorder | ||
* Treatment of | * Treatment of irritability associated with autistic disorder | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2 and dopamine D2 receptors | |||
==Route of Administration== | ==Route of Administration== | ||
* Oral (tablets and oral solution) | |||
* Intramuscular injection (long-acting injectable form) | |||
==Dosages== | ==Dosages== | ||
* Schizophrenia ( | * Schizophrenia (adults): Initial dose 2 mg/day, target dose 4 to 8 mg/day | ||
* Bipolar mania (adults): Initial dose 2 to 3 mg/day, target dose 1 to 6 mg/day | |||
* | |||
For | For moderate to severe renal impairment (eGFR < 60 mL/min/1.73 m2): | ||
* The maximum recommended dosage for schizophrenia is 3 mg per day. | |||
* The maximum recommended dosage for major depressive disorder is 2 mg per day. | |||
For patients with severe renal impairment (CrCl < 30 mL/min): | |||
* Initial dose: 0.5 mg twice daily | |||
* Titrate in increments of up to 0.5 mg twice daily | |||
* Increases above 1.5 mg twice daily should occur at intervals of at least one week | |||
==Side Effects== | ==Side Effects== | ||
| Line 58: | Line 60: | ||
!Adverse reactions | !Adverse reactions | ||
|- | |- | ||
| rowspan=" | | rowspan="13" | '''Common | ||
| | | Drowsiness | ||
|- | |- | ||
| | | Dizziness: which can increase the risk of falling | ||
|- | |- | ||
| | | Weight Gain: Increased appetite leading to weight gain | ||
|- | |- | ||
| | | Nausea: Feeling sick to the stomach | ||
|- | |- | ||
| | | Constipation | ||
|- | |- | ||
| Nausea | | Nausea | ||
|- | |- | ||
| | | Constipation | ||
|- | |||
| Dry Mouth: Reduced saliva production | |||
|- | |- | ||
| | | Increased Saliva: Excessive saliva production | ||
|- | |- | ||
| | | Anxiety: Feelings of nervousness or worry | ||
|- | |- | ||
| | | Agitation: Restlessness or irritability | ||
|- | |- | ||
| | | Difficulty Sleeping: Trouble falling or staying asleep | ||
|- | |- | ||
| | | Blurred Vision: Changes in vision clarity | ||
|- | |- | ||
| | | Runny or Stuffy Nose: Cold-like symptoms | ||
|- | |- | ||
| | | Fatigue: General feeling of tiredness | ||
|- | |- | ||
| | | rowspan="12" | '''Uncommon | ||
| Neuroleptic Malignant Syndrome (NMS): Symptoms include high fever, muscle stiffness, and altered mental status | |||
|- | |- | ||
| | | Tardive Dyskinesia**: Involuntary, repetitive movements, particularly of the face and limbs, which may be irreversible | ||
|- | |- | ||
| | | Metabolic Changes: Increased blood sugar, cholesterol and triglycerides, and weight gain, which can lead to diabetes | ||
|- | |- | ||
| | | Cognitive Impairment: Difficulty thinking or concentrating | ||
|- | |- | ||
| Difficulty | | Heat Intolerance: Difficulty regulating body temperature, leading to overheating or hypothermia | ||
|- | |- | ||
| | | Increased Risk of Falls: Particularly in elderly patients due to dizziness and drowsiness | ||
|- | |- | ||
| | | Orthostatic Hypotension: Sudden drop in blood pressure upon standing, leading to dizziness or fainting | ||
|- | |- | ||
| | | Seizures: Convulsions or fits | ||
|- | |- | ||
| | | Low White Blood Cell Count: Increased risk of infections | ||
|- | |- | ||
| | | Allergic Reactions: Symptoms include rash, itching, and trouble breathing | ||
|- | |- | ||
| | | Stroke: Increased risk in elderly patients with dementia-related psychosis | ||
|- | |||
| Increased Prolactin Levels: This can lead to breast milk production, menstrual irregularities, and sexual dysfunction | |||
|} | |} | ||
==Pharmacokinetics== | ==Pharmacokinetics== | ||
*Absorption | *Absorption | ||
**Peak plasma | **Peak plasma concentrations occurring within 1 to 2 hours | ||
*Metabolism | *Metabolism | ||
** | **Extensively metabolized in the liver by CYP2D6 | ||
* | *Elimination | ||
** | **Approximately 70% excreted in urine and 14% in feces. The half-life of the active moiety (risperidone plus 9-hydroxyrisperidone) is approximately 20 hours. | ||
Drug onset time and duration: Onset of action may be seen within 1 to 2 weeks, with full effects typically observed within 4-6 weeks. | |||
==Drug Precautions== | ==Drug Precautions== | ||
| Line 131: | Line 133: | ||
*May cause drowsiness, dizziness, and difficulty swallowing in elderly patients, increasing the risk of falls and choking | *May cause drowsiness, dizziness, and difficulty swallowing in elderly patients, increasing the risk of falls and choking | ||
''' | ''' Pregnancy | ||
*Use with caution; potential risks to the fetus should be considered | |||
''' | ''' Breastfeeding | ||
* | *Not recommended; risperidone is excreted in human milk | ||
'''Monitoring Requirements | '''Monitoring Requirements | ||
* | *Weight, blood glucose, lipid profile, prolactin levels, signs of extrapyramidal symptoms | ||
'''Drug Interactions | '''Drug Interactions | ||
* | *May enhance the effects of other CNS depressants; caution with drugs that prolong QT interval as risperidone may cause QT prolongation | ||
==FAQ== | ==FAQ== | ||
'''How Should I Take the Tablet? | '''How Should I Take the Tablet? | ||
* | * Take risperidone exactly as prescribed by your doctor, usually once or twice daily with or without food. | ||
''What should I avoid while taking | ''What should I avoid while taking? | ||
*Avoid alcohol | * Avoid alcohol and activities requiring mental alertness until you know how risperidone affects you. | ||
'''What Happens if I Miss a Dose? | '''What Happens if I Miss a Dose? | ||
*Take the missed dose as soon as you remember unless it is almost time for your next dose. Do not double doses | * Take the missed dose as soon as you remember unless it is almost time for your next dose. Do not double doses | ||
Revision as of 05:23, 8 July 2024
Drug class: Atypical antipsychotic
Risperidone (RISPERDAL)(中文:利培酮)
Pronunciation
Risperidone 1mg
Risperidone 2mg
Risperidone orodispersible 1mg
Risperidone orodispersible 2mg
Common Strengths of Risperidone Tablet
Brexpiprazole tablets are available in the following strengths:
- 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tablets; 1 mg/mL oral solution
Drug Trade Names of Risperidone Tablet
Risperdal, Risperdal Consta (long-acting injectable form)
Drug Usage
Risperidone is used for:
- Treatment of schizophrenia
- Acute treatment of manic or mixed episodes associated with bipolar disorder
- Treatment of irritability associated with autistic disorder
Mechanism of Action
Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2 and dopamine D2 receptors
Route of Administration
- Oral (tablets and oral solution)
- Intramuscular injection (long-acting injectable form)
Dosages
- Schizophrenia (adults): Initial dose 2 mg/day, target dose 4 to 8 mg/day
- Bipolar mania (adults): Initial dose 2 to 3 mg/day, target dose 1 to 6 mg/day
For moderate to severe renal impairment (eGFR < 60 mL/min/1.73 m2):
- The maximum recommended dosage for schizophrenia is 3 mg per day.
- The maximum recommended dosage for major depressive disorder is 2 mg per day.
For patients with severe renal impairment (CrCl < 30 mL/min):
- Initial dose: 0.5 mg twice daily
- Titrate in increments of up to 0.5 mg twice daily
- Increases above 1.5 mg twice daily should occur at intervals of at least one week
Side Effects
| Frequency | Adverse reactions |
|---|---|
| Common | Drowsiness |
| Dizziness: which can increase the risk of falling | |
| Weight Gain: Increased appetite leading to weight gain | |
| Nausea: Feeling sick to the stomach | |
| Constipation | |
| Nausea | |
| Constipation | |
| Dry Mouth: Reduced saliva production | |
| Increased Saliva: Excessive saliva production | |
| Anxiety: Feelings of nervousness or worry | |
| Agitation: Restlessness or irritability | |
| Difficulty Sleeping: Trouble falling or staying asleep | |
| Blurred Vision: Changes in vision clarity | |
| Runny or Stuffy Nose: Cold-like symptoms | |
| Fatigue: General feeling of tiredness | |
| Uncommon | Neuroleptic Malignant Syndrome (NMS): Symptoms include high fever, muscle stiffness, and altered mental status |
| Tardive Dyskinesia**: Involuntary, repetitive movements, particularly of the face and limbs, which may be irreversible | |
| Metabolic Changes: Increased blood sugar, cholesterol and triglycerides, and weight gain, which can lead to diabetes | |
| Cognitive Impairment: Difficulty thinking or concentrating | |
| Heat Intolerance: Difficulty regulating body temperature, leading to overheating or hypothermia | |
| Increased Risk of Falls: Particularly in elderly patients due to dizziness and drowsiness | |
| Orthostatic Hypotension: Sudden drop in blood pressure upon standing, leading to dizziness or fainting | |
| Seizures: Convulsions or fits | |
| Low White Blood Cell Count: Increased risk of infections | |
| Allergic Reactions: Symptoms include rash, itching, and trouble breathing | |
| Stroke: Increased risk in elderly patients with dementia-related psychosis | |
| Increased Prolactin Levels: This can lead to breast milk production, menstrual irregularities, and sexual dysfunction |
Pharmacokinetics
- Absorption
- Peak plasma concentrations occurring within 1 to 2 hours
- Metabolism
- Extensively metabolized in the liver by CYP2D6
- Elimination
- Approximately 70% excreted in urine and 14% in feces. The half-life of the active moiety (risperidone plus 9-hydroxyrisperidone) is approximately 20 hours.
Drug onset time and duration: Onset of action may be seen within 1 to 2 weeks, with full effects typically observed within 4-6 weeks.
Drug Precautions
Increased risk in elderly patients
- Should not be used to treat dementia-related psychosis in older adults due to increased risk of stroke and death
- May cause drowsiness, dizziness, and difficulty swallowing in elderly patients, increasing the risk of falls and choking
Pregnancy
- Use with caution; potential risks to the fetus should be considered
Breastfeeding
- Not recommended; risperidone is excreted in human milk
Monitoring Requirements
- Weight, blood glucose, lipid profile, prolactin levels, signs of extrapyramidal symptoms
Drug Interactions
- May enhance the effects of other CNS depressants; caution with drugs that prolong QT interval as risperidone may cause QT prolongation
FAQ
How Should I Take the Tablet?
- Take risperidone exactly as prescribed by your doctor, usually once or twice daily with or without food.
What should I avoid while taking?
- Avoid alcohol and activities requiring mental alertness until you know how risperidone affects you.
What Happens if I Miss a Dose?
- Take the missed dose as soon as you remember unless it is almost time for your next dose. Do not double doses
